title: [The administration of sandostatin in the combined treatment of acute pancreatitis and its complications].
abstract: Experience of application of the somatostatin synthetic analog sandostatin ("Novartis" firm) in treatment of 212 patients, including 84--with an acute pancreatitis (AP), 41--with postoperative AP (APP), 15--with external pancreatic fistula and 72--with high risk of the APP occurrence for prophylaxis was summarized. The significant inhibiting action of preparation on endocrine pancreatic function was noted. High efficacy of sandostatin in patients with AP and its complications was determined.
authors.forename: V F
authors.initials: VF
authors.lastname: Saenko
authors.forename: V I
authors.initials: VI
authors.lastname: Lupal'tsov
authors.forename: G F
authors.initials: GF
authors.lastname: Babenkov
authors.forename: V M
authors.initials: VM
authors.lastname: Kopchak
authors.forename: A P
authors.initials: AP
authors.lastname: Volzhanskiĭ
mesh_terms: D000208:Acute Disease; D003131:Combined Modality Therapy; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010185:Pancreatic Fistula / Q000188:drug therapy* / Q000209:etiology* / Q000601:surgery; D010195:Pancreatitis / Q000150:complications* / Q000188:drug therapy* / Q000601:surgery
chemical_list: D005765:Gastrointestinal Agents; D015282:Octreotide
vernacular_title: Primenenie sandostatina v komplekse lecheniia ostrogo pankreatita i iego oslozhneniĭ.